Atossa Therapeutics
ATOS
#9892
Rank
NZ$64.24 M
Marketcap
NZ$7.46
Share price
4.68%
Change (1 day)
452.25%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): NZ-$0.42

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.42. In 2024 the company made an earnings per share (EPS) of NZ-$0.33 an increase over its 2023 EPS that were of NZ-$0.40.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.4225.35%
2024NZ-$0.33-16.67%
2023NZ-$0.4014.29%
2022NZ-$0.3516.67%
2021NZ-$0.30-90.86%
2020NZ-$3.29-2.96%
2019NZ-$3.39-63.09%
2018NZ-$9.18-49.63%
2017NZ-$18.23-57.87%
2016NZ-$43.26-74.01%
2015NZ-$166.43-9.18%
2014NZ-$183.26-12.86%
2013NZ-$210.2970.73%
2012NZ-$123.1734.08%
2011NZ-$91.87263.47%
2010NZ-$25.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.59-4,554.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$14.42-3,556.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.11-4,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.47 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.35-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA